Radiotracing experiments demonstrated that tryptophan is greedily metabolized in MB patients (Xin et al., 2020) and its depletion from the tumor microenvironment is associated with the activity of tryptophan catabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1). Here, IDO1 is linked to neoplasm.